唐灵, 陈春莲, 苏桂兰. 2型糖尿病肾病患者内脂素、脂联素和C反应蛋白变化及其临床意义 [J]. 中国全科医学, 2011(8):2616.doi: 10.3969/j.issn.1007-9572.2011.23.010.
|
Navarro-Gonzalez J F, Mora-Femandez C, de Fuentes M M. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy [J]. Nature Reviews Nephrology, 2011(6):327.
|
薛存强. 2型糖尿病患者血清hs-CRP、IL-6及TNFa的检测意义 [J]. 医学检验与临床, 2009(3):105.doi: 10.3969/j.issn.1673-5013.2009.03.054.
|
梁宁, 郑青, 陈夏明. DN患者血清hs-CRP、TNF-α、M-CSF和HbA1c检测的临床意义 [J]. 放射免疫学杂志, 2009(3):243.doi: 10.3969/j.issn.1008-9810.2009.03.029.
|
Wenzel R R, Littke T, Kuranoff S. Avosentan reduces albumin excretion in diabetics with rnacroalbuminuria [J]. Journal of the American Society of Nephrology, 2009(3):655.
|
Shelbaya S, Amer H, Seddik S. Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients [J]. European Review for Medical and Pharmacological Sciences, 2012(2):176.
|
史春林. 2型糖尿病患者血清hs-CRP、TNF-α和Hcy水平及与糖尿病肾病的关系 [J]. 山东医药, 2009, (51):80.doi: 10.3969/j.issn.1002-266X.2009.51.038.
|
陈桂媛. 2型糖尿病患者血清hs-CRP和TC/HDL-C联合检测的应用研究 [J]. 实用医技杂志, 2008(3):301.doi: 10.3969/j.issn.1671-5098.2008.03.015.
|
Goud B K, Nayal B, Devi O S. Comparison of microalbuminuria with hs-CRP and low density lipoprotein levels in nondiabetic, nonhypertensive myocardial infarction patients [J]. J Cardiovasc Dis Res, 2012(4):287.
|
吴鑫. 同型半胱氨酸与超敏C反应蛋白在糖尿病肾病患者中的意义研究 [J]. 实用心脑肺血管病杂志, 2011(7):1127.doi: 10.3969/j.issn.1008-5971.2011.07.034.
|
孙芹敏, 孙闰华, 吕琳. 2型糖尿病患者超敏G反应蛋白和血脂检测的临床应用 [J]. 实用医学杂志, 2007(9):1405.doi: 10.3969/j.issn.1006-5725.2007.09.063.
|
Endre Z H, Pickering J W, Walker R J. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function [J]. Kidney International, 2011, (10):1119.
|
West MB, SeguZM, FeasleyCL. Analysisof sitespecific glycosylation of renal and hepatic γ-glutamyl transpeptidase from normal human tissue [J]. Journal of Biological Chemistry, 2010, (38):29511.
|